Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erick Strauss

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
ACS Infectious Diseases|May 8, 2020
Toward a Stable and Potent Coenzyme A-Targeting Antiplasmodial Agent: Structure-Activity Relationship Studies of <i>N</i>-Phenethyl-α-methyl-pantothenamideChristina Spry, Leanne Barnard, Michélle Kok, et al.
Molecular Microbiology|August 22, 2013
The Schizosaccharomyces pombe fusion gene hal3 encodes three distinct activitiesCristina Molero, Katalin Petrényi, Asier González, et al.
Biochemistry|September 8, 2012
Turnover-dependent covalent inactivation of Staphylococcus aureus coenzyme A-disulfide reductase by coenzyme A-mimetics: mechanistic and structural insightsBret D Wallace, Jonathan S Edwards, Jamie R Wallen, et al.
ACS Infectious Diseases|October 21, 2016
Discovery of Potent Pantothenamide Inhibitors of Staphylococcus aureus Pantothenate Kinase through a Minimal SAR Study: Inhibition Is Due to Trapping of the ProductScott J Hughes, Leanne Barnard, Katayoun Mottaghi, et al.
Chemistry & Biology|May 29, 2012
The antibiotic CJ-15,801 is an antimetabolite that hijacks and then inhibits CoA biosynthesisRenier van der Westhuyzen, Justin C Hammons, Jordan L Meier, et al.
Medchemcomm|March 25, 2020
Overcoming synthetic challenges in targeting coenzyme A biosynthesis with the antimicrobial natural product CJ-15,801Riyad Domingo, Renier van der Westhuyzen, Anton R Hamann, et al.
Plos Pathogens|April 4, 2018
Mutations in the pantothenate kinase of Plasmodium falciparum confer diverse sensitivity profiles to antiplasmodial pantothenate analoguesErick T Tjhin, Christina Spry, Alan L Sewell, et al.
The Journal of Biological Chemistry|July 23, 2025
Opt1 imports CoA precursors as glutathione mixed disulfidesJouke Jan Wedman, Lotte de Vries, Bart van Lingen, et al.
ACS Infectious Diseases|June 3, 2025
Metabolic Activation versus Masked Prodrugs: Bisubstrate Mimic Inhibitors of CoaBC's PPCS Activity in <i>Mycobacterium tuberculosis</i> and <i>Staphylococcus aureus</i>Timothy J Kotzé, Konrad J Mostert, Riyad Domingo, et al.
Science Advances|March 13, 2026
The <i>Plasmodium falciparum</i> PPCS is a unique heteromeric complex with prokaryote-like activity and is a target of pantothenate analogsXiangning Liu, Ruitao Jin, Riyad Domingo, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
ACS Infectious Diseases|May 8, 2020
Toward a Stable and Potent Coenzyme A-Targeting Antiplasmodial Agent: Structure-Activity Relationship Studies of <i>N</i>-Phenethyl-α-methyl-pantothenamideChristina Spry, Leanne Barnard, Michélle Kok, et al.
Molecular Microbiology|August 22, 2013
The Schizosaccharomyces pombe fusion gene hal3 encodes three distinct activitiesCristina Molero, Katalin Petrényi, Asier González, et al.
Biochemistry|September 8, 2012
Turnover-dependent covalent inactivation of Staphylococcus aureus coenzyme A-disulfide reductase by coenzyme A-mimetics: mechanistic and structural insightsBret D Wallace, Jonathan S Edwards, Jamie R Wallen, et al.
ACS Infectious Diseases|October 21, 2016
Discovery of Potent Pantothenamide Inhibitors of Staphylococcus aureus Pantothenate Kinase through a Minimal SAR Study: Inhibition Is Due to Trapping of the ProductScott J Hughes, Leanne Barnard, Katayoun Mottaghi, et al.
Chemistry & Biology|May 29, 2012
The antibiotic CJ-15,801 is an antimetabolite that hijacks and then inhibits CoA biosynthesisRenier van der Westhuyzen, Justin C Hammons, Jordan L Meier, et al.
Medchemcomm|March 25, 2020
Overcoming synthetic challenges in targeting coenzyme A biosynthesis with the antimicrobial natural product CJ-15,801Riyad Domingo, Renier van der Westhuyzen, Anton R Hamann, et al.
Plos Pathogens|April 4, 2018
Mutations in the pantothenate kinase of Plasmodium falciparum confer diverse sensitivity profiles to antiplasmodial pantothenate analoguesErick T Tjhin, Christina Spry, Alan L Sewell, et al.
The Journal of Biological Chemistry|July 23, 2025
Opt1 imports CoA precursors as glutathione mixed disulfidesJouke Jan Wedman, Lotte de Vries, Bart van Lingen, et al.
ACS Infectious Diseases|June 3, 2025
Metabolic Activation versus Masked Prodrugs: Bisubstrate Mimic Inhibitors of CoaBC's PPCS Activity in <i>Mycobacterium tuberculosis</i> and <i>Staphylococcus aureus</i>Timothy J Kotzé, Konrad J Mostert, Riyad Domingo, et al.
Science Advances|March 13, 2026
The <i>Plasmodium falciparum</i> PPCS is a unique heteromeric complex with prokaryote-like activity and is a target of pantothenate analogsXiangning Liu, Ruitao Jin, Riyad Domingo, et al.
Pageof 6